A selection of recent
publications from the
Samsara team
Publications
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms (2021) Journal for Immunotherapy of Cancer
Digesting the crisis: autophagy and coronaviruses (2020) Microbial Cell
Importance of Quantifying Drug-Target Engagement in Cells (2020) ACS Med. Chem. Lett.
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effects (2020) Autophagy
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential (2019) Cell Metabolism
Biological Functions of Autophagy Genes: A Disease Perspective (2019)
Yeast as a tool to identify anti-aging compounds (2018) Oxford Journals: FEMS Yeast Research
The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species (2018) Nature Communications
Therapeutic modulation of autophagy: Which disease comes first? (2019) Cell Death & Differentiation
The Hallmarks of Aging (2013) Cell
The Lysoseeker™ Platform
A unique approach for discovering new autophagy therapeutics.
Neurodegeneration
What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?
Rare Monogenic Disease
What if we could offer real hope for serious rare genetic diseases?
Our Pipeline
Samsara is leveraging its knowledge of new autophagy biology.
Samsara Therapeutics adds eminent neurologist Professor Dame Pamela Shaw to its scientific advisory board to help accelerate ALS/MND treatment development
Samsara Therapeutics, the autophagy biotech company, has appointed eminent neurologist and world-leading researcher in Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease (MND) Professor Dame Pamela Shaw to its scientific advisory board.
Samsara Therapeutics Parkinson’s drug receives funding boost from The Michael J. Fox Foundation
Samsara Therapeutics announced today that it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to further its research into a promising Parkinson’s disease drug.
Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson’s and motor neurone disease
Samsara Therapeutics is first in the race to find a viable, potent autophagy inducing drug, with the potential to give us longer and healthier lives.
Meet the Neuro Team – Modelling Neurodegeneration in a Dish
We caught up with Senior Scientists Gabriela Vilema Enríquez and Matthew Williamson on their work within the neuroscience team at Samsara.
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy